Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity
Authors:
- K. LewandowskiKLK. Lewandowski
- E. KolaczEKE. Kolacz
- K. ZawilskaKZK. Zawilska
- A. Warenik-SzymankiewiczAWA. Warenik-Szymankiewicz
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 22 (11) , 651-654
Abstract
The present study aimed to assess the fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome (PCOS) and to compare them in obese PCOS patients and women with simple obesity. We studied 19 obese women with PCOS (age: 25.1 +/- 4.6 years, body mass index (BMI): 34.7 +/- 3.9 kg/m2; mean +/- standard deviation) and 20 age- and BMI-matched ovulatory controls. We measured blood levels of 17beta-estradiol, testosterone, prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), dehydroepiandrosterone sulfate (DHEAS), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glucose and insulin. The following fibrinolytic tests were also performed: euglobulin clot lysis time, plasminogen level, alpha2-antiplasmin activity, plasminogen activator inhibitor-1 activity, fibrinogen concentration and estimated fibrinolytic activity. Testosterone and LH levels were significantly higher in obese women with PCOS (p < 0.01 and p < 0.001, respectively). The groups did not differ with regard to 17beta-estradiol, prolactin, FSH, DHEAS, TC, TG, HDL-C, LDL-C, glucose and insulin. All of the fibrinolysis parameters with the exception of plasminogen were comparable between the two groups. Serum plasminogen level was lower in obese PCOS patients than in women with simple obesity (p < 0.05). Euglobulin clot lysis time was positively correlated with insulin (r = 0.88, p < 0.05) in both groups. Our results show that fibrinolysis is not suppressed in women with PCOS and that there is no difference in fibrinolytic activity between obese patients with PCOS and women with simple obesity.Keywords
This publication has 14 references indexed in Scilit:
- Global Fibrinolytic Capacity Is Decreased in Polycystic Ovary Syndrome, Suggesting a Prothrombotic StateThe Journal of Clinical Endocrinology & Metabolism, 2002
- Polycystic ovary syndrome: A risk for coronary artery disease?American Journal of Obstetrics and Gynecology, 2002
- Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndromeMetabolism, 1999
- Coagulation abnormalities and cardiovascular diseaseCurrent Opinion in Lipidology, 1999
- Up-regulation of plasminogen activator inhibitor 2 (PAI-2) in response to α-lactalbuminFibrinolysis and Proteolysis, 1999
- Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI‐1) activity in lean women with and without the polycystic ovary syndromeClinical Endocrinology, 1996
- Effects of androgens on haemostasisMaturitas, 1996
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of womenActa Obstetricia et Gynecologica Scandinavica, 1992
- A Comparative Study of Coagulation and Fibrinolysis in Blood from Normal Men and WomenBritish Journal of Haematology, 1966